Expression of MAC-1 (CD11b) in Acute Myeloid Leukemia (AML) is associated with an unfavorable prognosis

American Journal of Hematology

Volumn 81, Issue 4, 2006, Pages 227-235

  Graf, Michaela ^a   Reif, Susanne ^a   Kröll, Tanja ^a   Hecht, Karin ^a   Nuessler, Volkmar ^b   Schmetzer, Helga ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute myeloid leukemia; CD11b; Immunophenotyping; Integrins; MAC 1; Prognosis

Indexed keywords

CD11B ANTIGEN; CELL ADHESION MOLECULE; CYTARABINE; DAUNORUBICIN; INTEGRIN; MITOXANTRONE; RETINOIC ACID; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CYTOGENETICS; DRUG MEGADOSE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PROTEIN INTERACTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD11B; BLAST CRISIS; COHORT STUDIES; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645701504     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20526     Document Type: Article

References (24)

1. Dercksen MW, Rodenhuis S, Dirkson MK, Schaasberg WP, Baars JW, van der Wall E, Slaper-Cortenbach IC, Pinedo HM, Von dem Bome AE, van der School CD, et al. Subsets of CD34 cells and rapid hematopoietic recovery after peripheral blood stem cell transplantation: J Clin Oncol 1995;13:1922-1932.
2. Reuss-Borst MA, Klein G, Waller HD, Müller CA. Differential expression of adhesion molecules in acute leukemia: Leukemia 1995;9:869-874.
3. Stucki A, Rivier AS, Gikic M, Monai N, Scapira M, Spertini O. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination: Blood 2001;97(7):2121-2129.
4. Schmetzer H, Wilmanns W, Gerhartz HH. Detection of acute myeloid leukemic cells in complete remission and in extramedullary sites by clonal analyses. Acta Haematol 1996;96:83-87.
5. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Annals of internal Medicine 1985;103:626-629.
6. Bene MC, Bernier M, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB for the European Group for the Immunological Classification of Leukemias (EGIL). Proposals for the immunological classification of acute leukaemias. Leukemia 1995;9:1783-1788.
7. Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, Pettenati MJ, Patil SR, Rao K, Watson MS, Koduru PRK, Moore JO, Stone RM, Mayer JR, Feldman EJ, Davey FR, Schiffer CA, Larson RA, Bloomfield CD. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B 2002 (CALGB 8461). Blood 100:4325-1336.
8. Rothe G, Schmitz G (Working group on Flow cytometry and Image Analyses). Consensus protocol for the flow cytometric immunophenotying of hematopoietic malignancies. Leukemia 1996;10:877-895.
9. Mitelman K. ISCN. An international system for human cytogenetic nomenclature. Karger: Basel 1995.
10. Mrozek K, Heinonen K, de la Chapelle A, Boomfield CD. Clinical significance of cytogenetics in Acute Myeloid Leukemia. Seminars in Oncology 1997;24:17-31.
11. Schoch C, Schnittger S, Klaus M, Kem W, Hiddemann W, Haferlach. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 2003;102(7):2395-2402.
12. Mazumdar M, Glassman JR. Tutorial in biostatistics. Categorizing a prognostic variable: Review of methods, code for easy implementation and applications to decision-making about cancer treatment. Statistics in Medicine 2000;19:113-132.
13. Reif S, Wiesner D, Duell T, Mittermueller J, Schmetzer H. Not the presence but the amount of clonal DNA detectable in remission of Acute Myeloid Leukemia (AML) is predictive for relapse. European Journal of Haematology 2001;67:207-222.
14. Paietta E, Andersen J, Wiernik PH. A new approach to analyzing the utility of immunophenotyping for predicting clinical outcome in acute leukemia. Leukemia, 1996;10:1-4.
15. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion mole cules. Blood 1994;84:2068-2101.
16. Paietta E, Andersen J, Yunis J, Rowe JM, Cassileth PA, Tallman MS, Bennett JM, Wiernik PH. Acute myeloid leukaemia expressing the leukocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. British J of Haematology, 1998;100:265-272.
17. Link DC. Mechanisms of granulocyte colony stimulating factor induced hematopoietic progenitor-cell mobilization: Semin Hematol 2000;37(Suppl. 2):25-32.
18. Simon DI, Rao NK, Xu H, Wei Y, Majdic O, Ronne E, Kobzik L, Chapman HA. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 1996;88:3185-3194.
19. Soligo D, Schiro R, Luksch R, Manara G, Quirici N, Parravicini C, Deliliers G. Expression of integrins in human bone marrow. Br J Haematol 1990;76:323-332.
20. + cells in AML and B-lineage ALL and their normal bone marrow coun terparts. Eur J Haematol. 1999;63(3):192-201.
21. Thin HF, Wang CH, Lin MT, Lee FY, Liu MC, Chuang SM, Chen YC, Shen MC, Lin KH, Lin DT. Correlation of cytogenetic results with immunophenotype, genotype, clinical features and ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan. (Abstract) Cancer Genet Cytogenet 1995;84:60-68.
22. Rosenfeld C, Kantarjian H. Is myelodysplastic related acute myeloid Leukemia a distinct entity from de novo acute myelogeneous Leukemia? Potential for targeted therapies. Leuk Lymphoma 2001;41:493-500.
23. Graf M, Reif S, Hecht K, Pelka-Fleischer, Kroell T, Pfister K, Schmetzer H. High Expression of Costimulatory Molecules Cor relates with Low Relapse Free-Survival-Probability in Acute Myeloid Leukemia (AML). Ann Hem, 2004;84:287-297.
24. Di Noto R, Lo Pardo C, Schiavone EM, Ferrara F, Manzo C, Vacca C, Del Vecchio L. All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia. Leuk Lymphoma 1996;21:201-209.